Earnings Feed
Start Free
ARIAD PHARMACEUTICALS INC·4

Mar 9, 5:14 PM ET

ARIAD PHARMACEUTICALS INC 4

4 · ARIAD PHARMACEUTICALS INC · Filed Mar 9, 2016

Insider Transaction Report

Form 4
Period: 2016-03-07
ARIAD PHARMACEUTICALS INCARIA
Haluska Frank
VP, Clinical R&D, CMO
Transactions
  • Award

    Restricted Stock Units

    2016-03-07+18,000→ 18,000 total
    Exercise: $0.00→ Common Stock (18,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2016-03-07$6.51/sh+60,000$390,600→ 60,000 total
    Exercise: $6.51→ Common Stock (60,000 underlying)
Footnotes (4)
  • [F1]Options vest 25% per year on the anniversary of the grant
  • [F2]Options expire 10 years from grant date
  • [F3]Restricted Stock Units vest as to 33-1/3% per year on the anniversary of the grant
  • [F4]N/A

Documents

1 file
  • 4
    wf-form4_145756166591446.xmlPrimary

    FORM 4